Skip to main content
logo
Biotricity, Inc. (BTCY)
OTCMKTS · Delayed Price · Currency is USD
0.6400
+0.0490 (8.29%)
Oct 13, 2025, 10:49 AM EDT

Biotricity Revenue

Biotricity had revenue of $3.87M in the quarter ending June 30, 2025, with 21.00% growth. This brings the company's revenue in the last twelve months to $14.46M, up 18.12% year-over-year. In the fiscal year ending March 31, 2025, Biotricity had annual revenue of $13.79M with 14.32% growth.

Revenue (ttm)
14.46M
Revenue Growth
+18.12%
P/S Ratio
1.10
Revenue / Employee
314.40K
Employees
46
Market Cap
15.93M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202513.79M1.73M14.32%
Mar 31, 202412.06M2.42M25.15%
Mar 31, 20239.64M1.99M26.00%
Mar 31, 20227.65M4.27M126.02%
Mar 31, 20213.38M1.97M138.75%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Elite Pharmaceuticals105.45M
Glass House Brands221.55M
Veradigm588.02M
Northwest Biotherapeutics1.09M
American Oncology Network1.76B
Silence Therapeutics27.17M
Jushi Holdings256.36M
Nuo Therapeutics1.95M
Revenue Rankings

Biotricity News

More News